4.070USD+5.17%Mkt Cap: 323.33M $P/E: —1d ago
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Cheaper
1M Perf
Lower
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap323.33M $
Enterprise Value-16.79M $
Revenue (TTM)20.34M $
Gross Profit20.34M $
Net Income (TTM)-8.61M $
Revenue/Share3.235 USD
Last Price4.070 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees18
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS8112922005
Valuation
P/E (Trailing)—
P/E (Forward)-1.62
PEG—
EV/EBITDA—
EV/Revenue-0.83
P/S1.99
P/B0.76
EPS (TTM)-3.84
EPS (Forward)-2.52
52W Range
0.565069% of range5.620
52W High5.620 USD
52W Low0.5650 USD
Profitability
Gross Margin100.00%
Oper. Margin-119.95%
EBITDA Margin0.00%
Profit Margin-41.79%
ROE-17.44%
ROA-14.58%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.28M $
CapEx (TTM)—
FCF Margin11.85%
FCF Yield0.75%
Net Debt-57.20M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.04
Current Ratio3.94
Quick Ratio3.73
Book Value/Sh5.326 USD
Cash/Share5.968 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 17, 2020
Splits
Last Split1:8
Split DateJun 1, 2026
Analyst Consensus
Rating—
Target (Mean)33.55 USD
Upside (mean)+724.2%
Target Range24.00 USD – 44.64 USD
$24.00+724.2% to mean$44.64
# Analysts3
Ownership
Shares Out.79.44M
Float7.70M
Insiders1.85%
Institutions53.27%
Short Interest
Short Ratio4.9d
Short % Float3.29%
Short % Out.3.22%
Shares Short320.18K
Short (prev mo.)284.22K
Technical
SMA 505.881 (-30.8%)
SMA 2006.127 (-33.6%)
Beta1.06
S&P 52W Chg20.05%
Avg Vol (30d)191.73K
Avg Vol (10d)82.23K
Technical Indicators
RSI (14)64.0
MACD0.4474
MACD Signal0.5806
MACD Hist.-0.1332
BB Upper4.976 USD
BB Middle4.196 USD
BB Lower3.417 USD
BB Width37.15%
ATR (14)0.3080 USD
Vol Ratio (20d)1.78x